Merck Sharp & Dohme
Assoc. Dir., Global Marketing
Merck Sharp & Dohme, Rahway, New Jersey, us, 07065
Job Description
It is an exciting time to join our company's Global Cardiometabolic & Respiratory Team, as we build an industry leading (CMR) business and aspire to impact cardiovascular disease on a global scale. We have made significant progress advancing our broad pipeline this year. Additionally, we expect eight approvals across our Cardiometabolic portfolio in the next five years. The Cardiometabolic business is a top corporate priority and expected to be a key growth driver for our company.
The Associate Director of Global Marketing for a first-in-class treatment will be responsible for supporting key commercial elements related to the launch success for a key growth driver for the company. This is a business-critical role that will be instrumental in helping our Company build a leadership position in the Pulmonary Arterial Hypertension/Pulmonary Hypertension (PAH/PH) therapeutic category and contributing to establishing CMR as a key growth driver for our Company. This role reports to the Executive Director of Global Marketing for a first-in-class treatment and will collaborate broadly with cross-functional partners to support enterprise-wide commercialization.
Pulmonary Arterial Hypertension is a rare disease with a high morbidity and mortality impacting patients and their loved ones. Despite a multitude of approved therapies, unmet need persists and there is widespread consensus among payers, clinicians and patients that more treatment options are needed to improve the management of this debilitating disease. Our Company’s ability to make a meaningful impact on this disease for patients and their loved ones will be influenced by the leadership of this role.
Specific Job Tasks Include:
Support the development of a Scientific Leader engagement strategy that optimizes the customer experience and minimizes points of friction, including medical education, congress strategy and expert input/consulting agreements.
Embed Scientific Leader insights into the development of all brand elements to contribute to the development of a robust brand and portfolio strategy with clear product differentiation.
Support medical education initiatives to increase awareness of a first-in-class treatment, the PAH disease state, and drive business growth in key markets.
Lead key congresses end to end strategy and execution for a first-in-class treatment across the key congresses worldwide and highlighting our Company's leadership and innovation in the PAH space.
Manage communications aligned with the global engagement model for a first-in-class treatment, updating key markets on launch readiness, key timelines, and market events.
Execute global marketing engagement model meetings (virtual and live) with key HHI partners and key cross-functional partners, which are critical to co-create the global strategy and ensure pull through.
Collaborate with Global Marketing, Regional Commercial Leaders, international markets and cross-functional partners (medical, policy, outcomes research, access, advocacy, etc.) to optimize the value of a first-in-class treatment.
As a member of the global Marketing organization, partner with colleagues in the Global Cardiometabolic Respiratory Franchise to invest in each other’s development, build a culture of inclusivity, speak-up and stretch our collective team’s thinking by challenging the status quo for the purpose of creating stronger outcomes.
Position Qualifications:
Education:
Bachelor's Degree
Preferred Education:
Advanced Degree (MBA)
Knowledge and Skills:
Minimum of 5 years of progressive knowledge and experience across marketing, sales, market access or related experiences in pharmaceutical, biotechnology or other regulated industries.
Preferred Knowledge and Skills:
Prior launch experience preferred.
Leadership and Impact: Proven track record of high-performance launches and driving business results.
Communication and executive presence: Ability to clearly articulate messages/information across the enterprise and to all levels, including highest levels of senior leadership.
Innovative Thinking: Demonstrated ability to leverage innovation to drive results.
Collaboration & Influence without authority: Strong collaboration skills, both within commercial teams and cross divisional teams including R&D and manufacturing, medical affairs, Outcomes Research and Access.
Understanding of Drug Development Process (Early and Late Stage).
Strategic Thinking: Proven ability to analyze complex data and create clear patient and customer centric strategies.
Challenging Status Quo: Ability to push past internal obstacles to drive initiatives forward.
Employee Status:
Regular
Relocation:
Domestic
VISA Sponsorship:
No
Travel Requirements:
25%
Flexible Work Arrangements:
Hybrid
Job Posting End Date:
11/12/2024
Requisition ID:
R317829
#J-18808-Ljbffr
It is an exciting time to join our company's Global Cardiometabolic & Respiratory Team, as we build an industry leading (CMR) business and aspire to impact cardiovascular disease on a global scale. We have made significant progress advancing our broad pipeline this year. Additionally, we expect eight approvals across our Cardiometabolic portfolio in the next five years. The Cardiometabolic business is a top corporate priority and expected to be a key growth driver for our company.
The Associate Director of Global Marketing for a first-in-class treatment will be responsible for supporting key commercial elements related to the launch success for a key growth driver for the company. This is a business-critical role that will be instrumental in helping our Company build a leadership position in the Pulmonary Arterial Hypertension/Pulmonary Hypertension (PAH/PH) therapeutic category and contributing to establishing CMR as a key growth driver for our Company. This role reports to the Executive Director of Global Marketing for a first-in-class treatment and will collaborate broadly with cross-functional partners to support enterprise-wide commercialization.
Pulmonary Arterial Hypertension is a rare disease with a high morbidity and mortality impacting patients and their loved ones. Despite a multitude of approved therapies, unmet need persists and there is widespread consensus among payers, clinicians and patients that more treatment options are needed to improve the management of this debilitating disease. Our Company’s ability to make a meaningful impact on this disease for patients and their loved ones will be influenced by the leadership of this role.
Specific Job Tasks Include:
Support the development of a Scientific Leader engagement strategy that optimizes the customer experience and minimizes points of friction, including medical education, congress strategy and expert input/consulting agreements.
Embed Scientific Leader insights into the development of all brand elements to contribute to the development of a robust brand and portfolio strategy with clear product differentiation.
Support medical education initiatives to increase awareness of a first-in-class treatment, the PAH disease state, and drive business growth in key markets.
Lead key congresses end to end strategy and execution for a first-in-class treatment across the key congresses worldwide and highlighting our Company's leadership and innovation in the PAH space.
Manage communications aligned with the global engagement model for a first-in-class treatment, updating key markets on launch readiness, key timelines, and market events.
Execute global marketing engagement model meetings (virtual and live) with key HHI partners and key cross-functional partners, which are critical to co-create the global strategy and ensure pull through.
Collaborate with Global Marketing, Regional Commercial Leaders, international markets and cross-functional partners (medical, policy, outcomes research, access, advocacy, etc.) to optimize the value of a first-in-class treatment.
As a member of the global Marketing organization, partner with colleagues in the Global Cardiometabolic Respiratory Franchise to invest in each other’s development, build a culture of inclusivity, speak-up and stretch our collective team’s thinking by challenging the status quo for the purpose of creating stronger outcomes.
Position Qualifications:
Education:
Bachelor's Degree
Preferred Education:
Advanced Degree (MBA)
Knowledge and Skills:
Minimum of 5 years of progressive knowledge and experience across marketing, sales, market access or related experiences in pharmaceutical, biotechnology or other regulated industries.
Preferred Knowledge and Skills:
Prior launch experience preferred.
Leadership and Impact: Proven track record of high-performance launches and driving business results.
Communication and executive presence: Ability to clearly articulate messages/information across the enterprise and to all levels, including highest levels of senior leadership.
Innovative Thinking: Demonstrated ability to leverage innovation to drive results.
Collaboration & Influence without authority: Strong collaboration skills, both within commercial teams and cross divisional teams including R&D and manufacturing, medical affairs, Outcomes Research and Access.
Understanding of Drug Development Process (Early and Late Stage).
Strategic Thinking: Proven ability to analyze complex data and create clear patient and customer centric strategies.
Challenging Status Quo: Ability to push past internal obstacles to drive initiatives forward.
Employee Status:
Regular
Relocation:
Domestic
VISA Sponsorship:
No
Travel Requirements:
25%
Flexible Work Arrangements:
Hybrid
Job Posting End Date:
11/12/2024
Requisition ID:
R317829
#J-18808-Ljbffr